(COVID-19) NEUTRALIZING ANTIBODY

The COVID-19 Neutralizing Antibody Test is a specialized blood test that measures the presence and activity of neutralizing antibodies against SARS-CoV-2, the virus responsible for COVID-19. Unlike standard antibody tests, this assay evaluates the ability of antibodies in the patient’s serum to block the virus from entering human cells, providing valuable information about the body’s protective immune response following natural infection or COVID-19 vaccination.

This test is commonly used to assess the effectiveness of COVID-19 vaccines, evaluate the immune response after infection, and support the screening of convalescent plasma donors for potential therapeutic or prophylactic use. It is particularly useful in research settings, clinical follow-up, and for individuals whose immune response needs to be evaluated. The results should always be interpreted in conjunction with the patient’s vaccination history, previous COVID-19 infection, clinical condition, and other laboratory findings. While the presence of neutralizing antibodies suggests an immune response, it does not guarantee complete protection against future COVID-19 infection.